Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Preferred Stock Liabilities (2020 - 2021)

GeneDx Holdings (WGS) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $334.4 million as the latest value for Q2 2021.

  • On a quarterly basis, Preferred Stock Liabilities rose 54.04% to $334.4 million in Q2 2021 year-over-year; TTM through Jun 2021 was $334.4 million, a 54.04% increase, with the full-year FY2020 number at $334.4 million, up 54.04% from a year prior.
  • Preferred Stock Liabilities was $334.4 million for Q2 2021 at GeneDx Holdings, roughly flat from $334.4 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $334.4 million in Q3 2020 to a low of $217.1 million in Q2 2020.